BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $561,000 | -9.1% | 48,000 | -4.0% | 0.00% | 0.0% |
| Q1 2017 | $617,000 | -3.6% | 50,000 | +6.4% | 0.00% | 0.0% |
| Q4 2016 | $640,000 | -35.7% | 47,000 | -6.0% | 0.00% | -40.0% |
| Q3 2016 | $995,000 | +60.2% | 50,000 | +4.4% | 0.01% | +66.7% |
| Q2 2016 | $621,000 | +67.8% | 47,900 | +21.0% | 0.00% | +50.0% |
| Q1 2016 | $370,000 | -56.1% | 39,600 | -4.8% | 0.00% | -50.0% |
| Q4 2015 | $843,000 | – | 41,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |